Biotech: Pressemitteilungen - Kategorie - Seite 30

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Ibalizumab Phase III Study Primary End-Point Results to Be Presented at IDWeek 2016

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 08/18/16 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that the abstract for the primary end-point results of the ibalizumab phase III ...

Prima BioMed Ltd: Operational Update

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 08/18/16 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD), has provided an update on the Company's cash position and the recruitment progress in its two active ...

Tiziana Life Sciences PLC: Change of Registered Office

LONDON, UNITED KINGDOM: LONDON, UNITED KINGDOM -- (Marketwired) -- 08/18/16 -- Tiziana Life Sciences plc (AIM: TILS)AIM: TILSLondon, 18 August 2016 - Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology com ...

BioCorRx, Inc. Announces Agreement With Dr. David Gastfriend to Provide Strategic Initiative and Corporate Development Consulting

LOS ANGELES, CA: LOS ANGELES, CA -- (Marketwired) -- 08/17/16 -- (OTC PINK: BICX), developer of the BioCorRx® Recovery Program, a Medication-Assisted Treatment (MAT) program, announces a consulting and advisory agr ...

Trillium Therapeutics Receives FDA Clearance to Proceed With TTI-621 in Clinical Trial Targeting Solid Tumors and Mycosis Fungoides

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/17/16 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), a clinical stage immuno-oncology company developing innovative therapies for the treatment of canc ...

True Nature Holding Names Jack P. Healey to Board of Directors

ATLANTA, GA: ATLANTA, GA -- (Marketwired) -- 08/16/16 -- True Nature Holding, Inc. (OTCQB: TNTY) today announced that it has appointed Mr. Jack Healey to its Board of Directors.True Nature CEO James Driscoll stat ...

Questex to Launch FierceBiotech Drug Development Forum in Boston

NEWTON, MA: NEWTON, MA -- (Marketwired) -- 08/15/16 -- , a leading global business information and events company, today announced the debut of , which will bring together leading pharmaceutical and biotech prof ...

Implications of Court Decision in Favor of iBio Against Fraunhofer

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 08/15/16 -- (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, commented further today on the imp ...

Cleveland BioLabs Reports Second Quarter 2016 Financial Results and Development Progress

BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 08/15/16 -- (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2016.Cleveland BioLabs reported a $(1.9) mi ...

Microbix Revenue Continues to Grow in Third Quarter

TORONTO, ONTARIO: Company Expects Record Revenue for 2016 ...

Atossa Genetics Announces Second Quarter 2016 Financial Results and Provides Company Update

SEATTLE, WA: Conference Call to Be Held Monday, August 15, 2016 at 4:30 pm Eastern Time ...

Flamel Technologies Launches Akovaz(TM)

LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 08/12/16 -- Flamel Technologies (NASDAQ: FLML) today announced the launch of Akovaz™, its formulation of ephedrine sulfate for injection, which received approval fr ...

Trillium Reports Second Quarter 2016 Financial Results

TORONTO, ONTARIO: On track to report clinical data from TTI-621 program at the end of 2016 IND submitted to initiate a Phase 1 trial with TTI-621 in solid tumors Cash amounted to $60.1 million (CDN) as of June 30, 2016 ...

RepliCel Life Sciences Announces Completion of the Final Injection in Its Tendon Repair Clinical Trial

VANCOUVER, BRITISH COLUMBIA: Initial Safety and Clinical Efficacy Data from the RCT-01 Trial is Expected to be Available for Analysis in December ...

Atossa Genetics to Provide Company Update and Discuss Second Quarter Financial Results on Conference Call on Monday, August 15, 2016

SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 08/10/16 -- (NASDAQ: ATOS) announced today that it will provide a Company update and discuss second quarter 2016 financial results on Monday, August 15, 2016 at 4:30 ...

Arch Biopartners Engages Catalent to Begin Manufacturing Process for AB569

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/10/16 -- Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE: ACH)(OTCBB: FOIFF) today announced it has engaged Catalent Inhalation, a division of Cata ...

Amphivena Therapeutics Announces Acceptance of Investigational New Drug (IND) Application for AMV564 and Planned Phase 1 Trial Initiation

SAN FRANCISCO, CA: Proprietary T-cell Redirecting Bispecific CD33/CD3 Antibody for the Treatment of AML Nears First-in-Human Study ...

Prima BioMed Receives NASDAQ Notice of Bid Price Deficiency

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 08/10/16 -- Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima", the "Company"), has received notification from the Listing Qualifications De ...


Seite 30 von 255:  « ..  29 30 31  32  33  34  35  36  37  38  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z